Skip to content

Public FDA record

Z-0508-2020: Synchromed II programmable pump, Model numbers 8637-20 and 8637-40

Recall record Z-0508-2020 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0508-2020
Company in FDA record
Medtronic Neuromodulation
FDA classification date
Dec 3, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

There is a potential for the presence of a foreign particle inside the pump motor assembly which could interfere with the motor gear rotation and lead to a permanent motor stall.

Source facts

Action
Medtronic Representatives began communicating to consignees starting 10/09/2019. Beginning 10/11/2019, Medtronic sent letters via mail. The letters explained the issue and requested the return of any unused units.
Initiated
2019-10-11
Root cause
Process control
Terminated
2023-09-15
Distribution
US and Canada, Asia -Pacific (APAC), China, Europe, Middle East and Africa (EMAE), Latin America (LATAM)
Recall number
Z-0508-2020
Recall status
Terminated
CDRH record ID
177048
FDA classified
2019-12-03
Recall event number
84037

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗